THERAZONE ApS: Financial statements 2022
CVR: 27255574
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -82,900 and a net result of DKK -2,178,530 compared with DKK 1,376,292 the year before. Equity in the 2022 report amounted to DKK 42,493,289. The solvency ratio was 98.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -82,900
- Profit/Loss
- DKK -2,178,530
- Equity
- DKK 42,493,289
- Total Assets
- DKK 43,141,084
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -83 t. | -2.2 mio. | 42.5 mio. | 2 |
| 2021 | - | -102 t. | 1.4 mio. | 44.8 mio. | 1 |
| 2020 | - | -115 t. | 9.2 mio. | 43.5 mio. | - |
| 2019 | - | 13 t. | 7.7 mio. | 34.4 mio. | - |
| 2018 | - | -221 t. | -233 t. | 26.9 mio. | - |
Official annual report
Keep an eye on THERAZONE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
THERAZONE ApS has published its annual report for 2021. Gross profit came to DKK -101,849, and the net result was DKK 1,376,292.
About THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. The company has 2 employees (2026). In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.